Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]

H Woopen; J Sehouli; A Davis; Y C Lee; P A Cohen; A Ferrero; N Gleeson; A Jhingran; Y Kajimoto; J Mayadev; M P Barretina-Ginesta; S Sundar; N Suzuki; E van Dorst; F Joly

doi:10.1016/j.ctrv.2022.102431

Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]

H Woopen, J Sehouli, A Davis, Y C Lee, P A Cohen, A Ferrero, N Gleeson, A Jhingran, Y Kajimoto, J Mayadev, M P Barretina-Ginesta, S Sundar, N Suzuki, E van Dorst, F Joly

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	102431
Pages (from-to)	102431
Journal	Cancer Treatment Reviews
Volume	109
Early online date	5 Jul 2022
DOIs	https://doi.org/10.1016/j.ctrv.2022.102431
Publication status	Published - Sep 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ctrv.2022.102431

1 Review article

GCIG-Consensus Guideline for Long-term survivorship in Gynecologic Cancer: a position paper from the Gynecologic Cancer Intergroup (GCIG) symptom benefit committee
Woopen, H., Sehouli, J., Davis, A., Lee, Y. C., Cohen, P. A., Ferrero, A., Gleeson, N., Jhingran, A., Kajimoto, Y., Mayadev, J., Barretina-Ginesta, M. P., Sundar, S., Suzuki, N., van Dorst, E. & Joly, F., Jun 2022, In: Cancer Treatment Reviews. 107, 102396.
Research output: Contribution to journal › Review article › peer-review

3 Citations (Web of Science)

Cite this

Woopen, H., Sehouli, J., Davis, A., Lee, Y. C., Cohen, P. A., Ferrero, A., Gleeson, N., Jhingran, A., Kajimoto, Y., Mayadev, J., Barretina-Ginesta, M. P., Sundar, S., Suzuki, N., van Dorst, E., & Joly, F. (2022). Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]. Cancer Treatment Reviews, 109, 102431. [102431]. https://doi.org/10.1016/j.ctrv.2022.102431

@article{e97e4cbb952a46b69d10b7ab5e918b13,

title = "Erratum to {"}GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee{"} [Cancer Treatm. Rev. 107 (2022) 102396]",

author = "H Woopen and J Sehouli and A Davis and Lee, {Y C} and Cohen, {P A} and A Ferrero and N Gleeson and A Jhingran and Y Kajimoto and J Mayadev and Barretina-Ginesta, {M P} and S Sundar and N Suzuki and {van Dorst}, E and F Joly",

year = "2022",

month = sep,

doi = "10.1016/j.ctrv.2022.102431",

language = "English",

volume = "109",

pages = "102431",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

}

Woopen, H, Sehouli, J, Davis, A, Lee, YC , Cohen, PA, Ferrero, A, Gleeson, N, Jhingran, A, Kajimoto, Y, Mayadev, J, Barretina-Ginesta, MP, Sundar, S, Suzuki, N, van Dorst, E & Joly, F 2022, 'Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]', Cancer Treatment Reviews, vol. 109, 102431, pp. 102431. https://doi.org/10.1016/j.ctrv.2022.102431

Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer : A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]. / Woopen, H; Sehouli, J; Davis, A et al.

In: Cancer Treatment Reviews, Vol. 109, 102431, 09.2022, p. 102431.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer

T2 - A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]

AU - Woopen, H

AU - Sehouli, J

AU - Davis, A

AU - Lee, Y C

AU - Cohen, P A

AU - Ferrero, A

AU - Gleeson, N

AU - Jhingran, A

AU - Kajimoto, Y

AU - Mayadev, J

AU - Barretina-Ginesta, M P

AU - Sundar, S

AU - Suzuki, N

AU - van Dorst, E

AU - Joly, F

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.ctrv.2022.102431

DO - 10.1016/j.ctrv.2022.102431

M3 - Comment/debate

C2 - 35803179

VL - 109

SP - 102431

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

M1 - 102431

ER -

Woopen H, Sehouli J, Davis A, Lee YC , Cohen PA, Ferrero A et al. Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]. Cancer Treatment Reviews. 2022 Sep;109:102431. 102431. https://doi.org/10.1016/j.ctrv.2022.102431

Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]

UN SDGs

Access to Document

Research output

GCIG-Consensus Guideline for Long-term survivorship in Gynecologic Cancer: a position paper from the Gynecologic Cancer Intergroup (GCIG) symptom benefit committee

Cite this